PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, Keck Medical Center, University of Southern California, Los Angeles, CA.\', \'Department of Medicine, Keck Medical Center, University of Southern California, Los Angeles, CA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/TP.0000000000003953
?:hasPublicationType
?:journal
  • Transplantation
is ?:pmid of
?:pmid
?:pmid
  • 34519680
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.557
?:rankingScore_hIndex
  • 191
?:title
  • A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all